ISSN:
1432-1041
Schlagwort(e):
felodipine
;
nifedipine
;
clinical trial
;
Raynaud's phenomenon
;
adverse effects
Quelle:
Springer Online Journal Archives 1860-2000
Thema:
Chemie und Pharmazie
,
Medizin
Notizen:
Summary Sixteen patients participated in a double-blind cross-over trial comparing the effect of two dosages of the new calcium entry blocker, felodipine, with nifedipine in the treatment of Raynaud's phenomenon. The effect was evaluated using a symptom recording system. As no difference was found between the 3 treatments, the lower dose of felodipine (10 mg) may be preferable as only one dose per day is necessary.
Materialart:
Digitale Medien
URL:
http://dx.doi.org/10.1007/BF00558230
Permalink